Introduction {#s1}
============

Sucrose shows strong potential as an industrial feedstock for *E. coli*-based bioprocesses [@pone.0088688-Archer1]--[@pone.0088688-Vickers1]; in addition, sucrose utilisation is prevalent in pathogenic *E. coli* strains [@pone.0088688-Agbonlahor1], [@pone.0088688-Moritz1]. Approximately 50% of wild-type *Escherichia coli* strains can metabolize sucrose [@pone.0088688-Edwards1] and in clinical isolates of enteropathogenic *E. coli* (EPEC) this can rise to 90% [@pone.0088688-Agbonlahor1], [@pone.0088688-Moritz1]. Two mechanisms for sucrose metabolism have been described in strains of *E. coli*: the sucrose phosphotransferase system (PTS; [@pone.0088688-Schmid1]--[@pone.0088688-Schmid2] and the chromosomally-located sucrose catabolose (*csc*) regulon. The *csc* regulon was originally identified in *E. coli* EC3132 [@pone.0088688-Archer1], [@pone.0088688-Jahreis1], [@pone.0088688-Bockmann1] but it has also been identified in the genomes of enterohaemorrhagic *E. coli* (EHEC), enterotoxigenic *E. coli* (ETEC) [@pone.0088688-Perna1]--[@pone.0088688-Rasko1] and the non-pathogenic strain W [@pone.0088688-Archer1], [@pone.0088688-Sabri1].

In the *csc* system, sucrose is imported into the cell by the permease, CscB [@pone.0088688-SahinTth1]. This gene is essential for sucrose utilisation, and no other gene can provide sufficient levels of sucrose transport for growth on sucrose in a Δ*cscB* knockout [@pone.0088688-Sabri2]. Once in the cell, the sucrose is hydrolysed into fructose and glucose by the essential invertase, CscA [@pone.0088688-SahinTth2]. The *cscA* gene is also essential for sucrose utilisation [@pone.0088688-Sabri2]. A fructokinase (CscK) phosphorylates the fructose moeity [@pone.0088688-Bockmann1]. Sucrose utilization is tightly regulated, requiring both the absence of glucose and the presence of sucrose to allow for full induction of the regulon. In the presence of glucose, the regulon is under catabolite repression [@pone.0088688-Goerke1]--[@pone.0088688-Busby1]. Operons under catabolite repression are activated when a complex of cyclic AMP (cAMP) and cAMP receptor protein A (CrpA) bind to the promoter [@pone.0088688-Jahreis1]. The formation of this complex only occurs in the absence of glucose. Even in the absence of glucose, often these operons remain poorly expressed until such time as the cognate repressor is de-repressed *via* the action of an inducer. Repression of the divergently expressed *cscA* and *cscKB* operons by the regulator protein CscR is thought to occur *via* the *cscA* and *cscKB* operator binding sites located within the intergenic region between the two operons [@pone.0088688-Jahreis1]. Under typical conditions, induction of the regulon occurs when the repressor binds to an inducer, blocking access to the operator binding site. The inducer of the *csc* regulon has not yet been experimentally determined; however, based on similar systems [@pone.0088688-Lin1]--[@pone.0088688-Huber1] it is likely to be either the sucrose or a product of the metabolism of sucrose (glucose/fructose/other). Unusually, the *csc* regulon requires relatively high (\>1%) sucrose concentrations for de-repression [@pone.0088688-Arifin1], [@pone.0088688-Bockmann1], [@pone.0088688-Sabri1]. Deletion/truncation of the *cscR* gene results in de-repression of the regulon, allowing sucrose utilisation at low concentrations [@pone.0088688-Arifin1], [@pone.0088688-Bockmann1], . Mutations in *cscB* also confer growth on low sucrose concentrations [@pone.0088688-Bockmann2], presumably *via* increased transport rates and subsequent increased in intracellular sucrose resulting in induction of the operon.

Although the *csc* regulon is highly conserved, notable variation in the sucrose utilisation phenotype has been observed, especially among EPEC strains [@pone.0088688-Moritz1]. For example, strains from serotypes O157:H7 and O55:H7 have been described as "slow" sucrose fermenters as they produce only light pink colonies following growth on MacConkey agar supplemented with 1% sucrose [@pone.0088688-Moritz1]. Furthermore, when laboratory strains are engineered to use sucrose by over-expressing *csc* genes, widely varying growth rates (from doubling times of many hours to growth rates similar to those observed on glucose) are observed [@pone.0088688-Jahreis1], [@pone.0088688-Bockmann1], [@pone.0088688-Tsunekawa1]--[@pone.0088688-Schuerman1]. Large variations in growth rate upon introduction of the same genes imply a strain-specific limitation in either sucrose utilisation or induction, and suggest that genes outside of the *csc* regulon contribute to the efficiency of sucrose utilisation/induction. To examine this possibility, we used *E. coli* W, a non-pathogenic strain that utilises sucrose *via* the *csc* regulon and does not have a sucrose PTS [@pone.0088688-Archer1], as an experimental system. Although *E. coli* W is capable of growing very quickly on sucrose [@pone.0088688-Lee2], sucrose metabolism is repressed at concentrations below ∼1% [@pone.0088688-Arifin1], [@pone.0088688-Sabri1]. A transposon mutagenesis library was developed in this strain and screened on low (0.2%) sucrose.

Several strains with altered sucrose utilisation phenotypes were identified; one of these had an insertion in the trehalose repressor gene, *TreR*. Using targeted mutagenesis and qRT-PCR, we examined the mechanism of sucrose utilization in the WΔ*treR* mutant. Our data suggest that sucrose can be transported by the trehalose PTS transporter, TreB. The transported sucrose is insufficient for cell growth, but can facilitate induction of the *csc* operon and subsequent growth *via* cscB-mediated sucrose uptake. To our knowledge, this is the first time that TreB has been shown to capable of sucrose transport.

Materials and Methods {#s2}
=====================

Bacterial strains, media and growth conditions {#s2a}
----------------------------------------------

Bacterial strains and plasmids are shown in [Table 1](#pone-0088688-t001){ref-type="table"}. *E. coli* W (NCIMB 8666) was purchased from the National Collection of Industrial, Food and Marine Bacteria (NCIMB) (Aberdeen, UK). For general cloning and maintenance, *E. coli* strains were grown in LB medium [@pone.0088688-Sambrook1]. For sugar utilization experiments, M9 minimal medium [@pone.0088688-Sambrook1] supplemented with thiamine (1 mg/L) was used and supplemented with either 2 g/l sucrose (M9S2), 20 g/l sucrose (M9S20), or 1% w/v glycerol (M9Gly). Ampicillin (100 µg/mL), kanamycin (50 µg/mL), and/or chloramphenicol (25 µg/mL) were included in media where appropriate.

10.1371/journal.pone.0088688.t001

###### *E. coli* strains and plasmids used in this study.

![](pone.0088688.t001){#pone-0088688-t001-1}

  Strain                             Relevant genotype or phenotype characteristics                             Source
  --------------- ------------------------------------------------------------------------------------ -------------------------
  W                                                 Wild-type *csc*+                                             NCIMB
  WΔcscR                                             WΔ*cscR*::FRT                                      [@pone.0088688-Arifin1]
  Tn2                                           W *appC::*Tn*5* (Kan^R^)                                      This study
  Tn9                                           W *cyaA::*Tn*5* (Kan^R^)                                      This study
  Tn32                             W *mhpR::*Tn*5* and *cscB* L363F mutation (Kan^R^)                         This study
  Tn33                                          W *mutS::*Tn*5* (Kan^R^)                                      This study
  Tn34                   W with unknown Tn*5* insertion site and *cscB* L51F mutation (Kan^R^)                This study
  Tn51                   W with unknown Tn*5* insertion site and *cscB* L363F mutation (Kan^R^)               This study
  Tn52                    W with unknown Tn*5* insertion site and *cscB* F371V mutation Kan^R^                This study
  Tn53                   W with unknown Tn*5* insertion site and *cscR* Q57\* mutation (Kan^R^)               This study
  Tn54                                         W *pi349::*Tn*5* (Kan^R^)                                      This study
  Tn56                   W with unknown Tn*5* insertion site and *cscB* L51F mutation (Kan^R^)                This study
  Tn57                   W with unknown Tn*5* insertion site and *cscB* C327G mutation (Kan^R^)               This study
  Tn58                   W with unknown Tn*5* insertion site and *cscB* L51F mutation (Kan^R^)                This study
  Tn61                                          W *treR::*Tn*5* (Kan^R^)                                      This study
  Tn63                                          W *gspK::*Tn*5* (Kan^R^)                                      This study
  Tn65                                          W *gltS::*Tn*5* (Kan^R^)                                      This study
  Tn68                                          W *hyp::*Tn*5* (Kan^R^)                                       This study
  Tn69             W with Tn5 insertion mutations and *cscKB* operator binding site mutation (Kan^R^)         This study
  Tn84                                          W *truA::*Tn*5* (Kan^R^)                                      This study
  Tn86                     W with Tn5 insertion mutations and *cscB* L363F mutation (Kan^R^)                  This study
  Tn87                                          W *treR::*Tn*5* (Kan^R^)                                      This study
  WΔgltS 1                                           WΔ*gltS*::FRT                                            This study
  WΔgltS 2                                           WΔ*gltS*::FRT                                            This study
  WΔgltS 3                                           WΔ*gltS*::FRT                                            This study
  WΔ*gspK* 1                                         WΔ*gspK*::FRT                                            This study
  WΔ*gspK* 2                                         WΔ*gspK*::FRT                                            This study
  WΔ*gspK* 3                                         WΔ*gspK*::FRT                                            This study
  WΔ*mphR* 1                                         WΔ*mphR*::FRT                                            This study
  WΔ*mphR* 2                                         WΔ*mphR*::FRT                                            This study
  WΔ*mphR* 3                                         WΔ*mphR*::FRT                                            This study
  WΔ*treR* 1                                         WΔ*treR*::FRT                                            This study
  WΔ*treR* 2                                         WΔ*treR*::FRT                                            This study
  WΔ*treR* 3                                         WΔ*treR*::FRT                                            This study
  WΔtreRΔtreB 1                 WΔ*treR*::FRT Δ*treB*::FRT-*cat*-FRT. Parent: WΔ*treR* 1                      This study
  WΔtreRΔtreB 2                 WΔ*treR*::FRT Δ*treB*::FRT-*cat*-FRT. Parent: WΔ*treR* 2                      This study
  WΔtreRΔtreB 3                 WΔ*treR*::FRT Δ*treB*::FRT-*cat*-FRT. Parent: WΔ*treR* 3                      This study
  WΔtreRΔtreC 1                 WΔ*treR*::FRT Δ*treC*::FRT-*cat*-FRT. Parent: WΔ*treR* 1                      This study
  WΔtreRΔtreC 3                 WΔ*treR*::FRT Δ*treC*::FRT-*cat*-FRT. Parent: WΔ*treR* 3                      This study
  WΔtreRΔcscA 1                WΔ*treR*::FRT Δ *cscA*::FRT-*cat*-FRT. Parent: WΔ*treR* 1                      This study
  WΔtreRΔcscA 2                 WΔ*treR*::FRT Δ*cscA*::FRT-*cat*-FRT. Parent: WΔ*treR* 2                      This study
  WΔtreRΔcscA 3                WΔ*treR*::FRT Δ *cscA*::FRT-*cat*-FRT. Parent: WΔ*treR* 3                      This study
  WΔtreRΔcscB 1                 WΔ*treR*::FRT Δ*cscB*::FRT-*cat*-FRT. Parent: WΔ*treR* 1                      This study
  WΔtreRΔcscB 2                 WΔ*treR*::FRT Δ*cscB*::FRT-*cat*-FRT. Parent: WΔ*treR* 2                      This study
  WΔtreRΔcscB 3                 WΔ*treR*::FRT Δ*cscB*::FRT-*cat*-FRT. Parent: WΔ*treR* 3                      This study

*csc* ^LS+^: positive growth on low sucrose (2 g/l).

Amp^R^, ampillicin resistance (100 µg/mL).

Kan^R^, kanamycin resistance (50 µg/mL).

Chl^R^, chloramphenicol resistance (40 µg/mL).

General molecular biology {#s2b}
-------------------------

General molecular biology techniques were performed according to standard protocols [@pone.0088688-Sambrook1]. Genomic DNA extraction was performed using either the Ultraclean® Microbial DNA Isolation kit (MO BIO Laboratories, Inc, CA) or the RBC Genomic Extraction kit (RBC bioscience, Taiwan) as per the manufacturers\' instructions. Oligonucleotide primers used in this study are shown in [Table 2](#pone-0088688-t002){ref-type="table"}.

10.1371/journal.pone.0088688.t002

###### Primers used in this study.

![](pone.0088688.t002){#pone-0088688-t002-2}

  Name                                     Sequence (5′ -- 3′)                                                 Application
  ----------- ----------------------------------------------------------------------------- --------------------------------------------------
  JSP07                              ACCTACAACAAAGCTCTCATCAACCGTGGC                          PCR/Sequencing [\*](#nt105){ref-type="table-fn"}
  cscA_F2                              ATGTCAGCCAAAGTATGGGTTTTAGG                                             PCR/Sequencing
  cscA_R2                                 TTAACCCAGTAGCCAGAGTGC                                               PCR/Sequencing
  cscA_R3                                 CAGATCAGGCCGTTTGGATC                                                PCR/Sequencing
  cscB_F2                               ATGGCACTGAATATTCCATTCAGA                                              PCR/Sequencing
  cscB_R2                               CTATATTGCTGAAGGTACAGGCGT                                              PCR/Sequencing
  cscK_R3                                 GACTCCCTCAGTTAGCAGCG                                                PCR/Sequencing
  cscK_F1                                 GCCGGGTTACTCACAGGTCTG                                               PCR/Sequencing
  cscK_R1                                 TTCGCCGTTACTGCAAGCGCT                                               PCR/Sequencing
  cscR_F3                                CAGCTTCCACATGACATTATCG                                               PCR/Sequencing
  cscOP_F1c                           GCTCTAGAGGATACTGGGCGATGAGCGAG                                           PCR/Sequencing
  cscOP_Rc                           GCTCTAGACGACAATGTCCTGGAAATCAGC                                           PCR/Sequencing
  cscR_R2                                  TCAGGTGGAACAACGGATC                                                PCR/Sequencing
  cscR_F1                               GTAACGATCGCGCAGCCTTTGTGG                                              PCR/Sequencing
  glts_F                                  CTGCGCGATGAAGTATGACG                                                PCR/Sequencing
  glts_R                                  GTTTCCCATACACAGAGCAC                                                PCR/Sequencing
  gspK_F                                  CTCATGCAGCAAACGATGAG                                                PCR/Sequencing
  gspK_R                                  AGCAACGTCAGACCAGATAC                                                PCR/Sequencing
  mphR_F                                  CGTTTTCAGGTGCAAGGTCA                                                PCR/Sequencing
  mphR_R                                  GCGACATCGTATAGCGTTAC                                                PCR/Sequencing
  treR_F                                  GGCAATGCGCACTTAAGGAC                                                PCR/Sequencing
  treR_R                                  CTGCAGAATATATTGCGCGG                                                PCR/Sequencing
  treB_F                                  CCTGATCGTTTCCTGAACGA                                                PCR/Sequencing
  treB_R                                 GTCATTACGTTATTCCTGCAAA                                               PCR/Sequencing
  treC_F                                  CCTCGTTTATCTATCAGCGG                                                PCR/Sequencing
  treC_R                                  CAACATGCTGACAGACAAAAC                                               PCR/Sequencing
  gltS KO_F      ATGTTTCATCTCGATACTTTAGCAACGCTTGTTGCCGCAACGCTGACGTTGTGTAGGCTGGAGCTGCTTC                        Mutagenesis
  glts KO_R      TTAACCGGCAAAAATCGGCAACATTAAATACAGCTTAATCACCAGCGCATCATATGAATATCCTCCTTAG                        Mutagenesis
  gspK KO_F      ATGATCACCTCACCACCAAAACGCGGAATGGCACTGGTCGTGGTGCTGGTGTGTAGGCTGGAGCTGCTTC                        Mutagenesis
  gspK KO_R      TCACTCACTTTCTCCTGTCTGATGCCAGAGAACCGAAAAGTGTTGTGGGCCATATGAATATCCTCCTTAG                        Mutagenesis
  mphR KO_F      ATGATTTTTTATTGTGCGCTCAGTATAGGAAGGGTGTTTTCGGCTACAATGTGTAGGCTGGAGCTGCTTC                        Mutagenesis
  mphR KO_R      TTAACGCAAATGCACGCCGCTTCGCCGTCCGGCCACCAGAATAGCCTGCGCATATGAATATCCTCCTTAG                        Mutagenesis
  treR KO_F      AGGATGCAAAATCGGCTGACCATCAAAGACATCGCACGCTTAAGCGGCGTGTGTAGGCTGGAGCTGCTTC                        Mutagenesis
  treR KO_R      GATGATGATTTGTTGCGGTTCGCTGCGCCCGGTTACCTGTGCGATCAATTCATATGAATATCCTCCTTAG                        Mutagenesis
  treB KO_F      TGATGAGCAAAATAAACCAAACGGATATCGATCGGTTGATTGAACTGGTCACATATGAATATCCTCCTTAG                       Mutagenesis
  treB KO_R      AACAATATCCAGCGTGCCCAGGCGGTATTTCCGCTGATAGATAAACGAGGAGTGTAGGCTGGAGCTGCTTC                       Mutagenesis
  treC KO_F      ACTAATCTTCCCCACTGGTGGCAAAACGGCGTTATCTACCAGATTTATCCACATATGAATATCCTCCTTAG                       Mutagenesis
  treC KO_R      ACTTCTGTAACCACCAGACAGCCTCAAAAGGCCGTAAATTCATGGCACAGAGTGTAGGCTGGAGCTGCTTC                       Mutagenesis
  cscA KO_F    CAATTCACCAAATTTGCTTAACCAGGATGATTAAAATGACGCAATCTCGATTGCATGGTGTAGGCTGGAGCTGCT                     Mutagenesis
  KOcscA_R2    TATGTTAACCCAGTAGCCAGAGTGCTCCATGTTGCAGCACAGCCACTCCGTGGGACATATGAATATCCTCCTTAG                     Mutagenesis
  KOcscB_F     GAATTTTTTAACGACAGGCAGGTAATTATGGCACTGAATATTCCATTCAGAAATGGTGTAGGCTGGAGCTGCTTC                     Mutagenesis
  KOcscB_R     CCGGTTGAGGGATATAGAGCTATCGACAACAACCGGAAAAAGTTTACGTCTATATCATATGAATATCCTCCTTAG                     Mutagenesis
  dld_F1                                 AGCACCCTGCGTCTCGACAAGC                                                  qRT-PCR
  dld_R1                                CACGACGATCCAATCACCGAGTGC                                                 qRT-PCR
  cscA QRT                               GTCCGGACATTCCCACATATAG                                                  qRT-PCR
  cscA QRT                               AGGCAACACGGGGCAGATCCTG                                                  qRT-PCR

\* Used for the direct sequencing of Tn*5* insertion sites from purified genomic DNA.

Generation and screening of Tn5 mutants with altered sucrose utilization phenotypes {#s2c}
-----------------------------------------------------------------------------------

A library of ∼10 000 random *E. coli* W mutants was generated using the EZ-Tn5™ \<KAN-2\> Tnp Transposome™ kit (Epicentre Biotechnologies, WI) as per the manufacturer\'s instructions to generate transformants containing only one Tn5 insertion. Following transformation, cells were immediately plated onto LB agar containing kanamycin. The library was screened by patching onto M9S2, M9S20 and MacConkey (1% sucrose) plates to identify sucrose utilization mutants. Tn5 insertion sites were identified by direct Sanger sequencing of purified genomic DNA as described previously [@pone.0088688-Murray1] using primer JSP07 ([Table 2](#pone-0088688-t002){ref-type="table"}) and analyzed by Micromon Sequencing Facility (Clayton, VIC. Australia). To identify nucleotide changes within the *csc* regulon, overlapping PCR products were generated, purified using MinElute PCR purification kit (QIAgen, Doncaster, VIC, Australia) and subsequently sequenced by the Australian Genome Research Facility (Brisbane, QLD Australia) using the Sanger method.

Site directed chromosomal gene knock-out {#s2d}
----------------------------------------

Chromosomal gene knock-out was performed using one-step homologous recombination [@pone.0088688-Datsenko1], with minor modifications as described previously [@pone.0088688-Sabri2], [@pone.0088688-Bruschi2], [@pone.0088688-Sabri3]. Primers used to amplify gene knock-out constructs using pKD3 [@pone.0088688-Datsenko1] as template are shown in [Table 2](#pone-0088688-t002){ref-type="table"}. The *cscB* gene is in the same operon as, and immediately downstream from, *cscK*; for this reason, particular care was taken in the primer design to ensure that *cscK* would not be disrupted. Transformants were selected on chloramphenicol and deletion of the target gene(s) was confirmed by PCR amplification across the knock-out locus and subsequent Sanger sequencing of the PCR product (see [Table 2](#pone-0088688-t002){ref-type="table"} for details of primers used). Where appropriate, the chloramphenicol resistance marker was removed by Flp recombinase as described previously [@pone.0088688-Datsenko1], [@pone.0088688-Cherepanov1]. Precise excision of the chloramphenicol resistance gene was also confirmed by PCR and sequencing. The resulting knock-out strains are listed in [Table 1](#pone-0088688-t001){ref-type="table"}.

Growth rate analysis {#s2e}
--------------------

Growth rates were analyzed in a 96-well microtitre plate format as described previously [@pone.0088688-Bruschi1] except that cultures were plated onto M9S20 agar and then M9S2 agar prior to pre-culture in M9S2. Growth rates of transposon and knock-out mutants were compared with the wild type *E. coli* W strain and the *cscR* knock-out (WΔ*cscR*) as controls

qRT-PCR {#s2f}
-------

Mutant and wild-type strains were cultured in M9 minimal media containing 1% glycerol with either 2% or 0.2% sucrose in shake flasks. At mid-log (OD600∼0.4) 10 ml of culture was harvested and immediately resuspended in 1 ml of TRI regent (Invitrogen). Each sample was heated at 70°C for 15 min before storage at −20°C. TRI extraction, DNaseI treatment (Promega) and RNeasy mini column (QIAgen) clean up were performed as per the manufacturer\'s instructions. PCR was used to confirm complete removal of contaminating genomic DNA from the RNA samples. cDNA was amplified from 600 ng total RNA using Superscript III (Invitrogen) as per the manufacturer\'s instructions with the following modifications: 50 ng of random hexamer (Invitrogen) was used and the reaction incubated at 50°C for 2.5 hr. An RT− control was performed alongside. RT+ and RT− template was diluted 1/200 with water before use. qRT-PCR was performed in a Corbett Rotor-Gene 3000 using Sybr green UDG mastermix (Invitrogen). Reactions were performed in 15 ul, containing 160 nM each oligo ([Table 2](#pone-0088688-t002){ref-type="table"}) and 2 ul of template. Each assay included (in duplicate): a standard curve generated with genomic DNA (gDNA) for each gene, and triplicate RT+ and duplicate RT− technical replicates for each of three biological replicates. Standard cycling conditions were used and melt curve analysis was performed, confirming only a single product was produced. A standard curve for each gene was determined and the efficiency of the reaction noted. C~t~ values were determined using the default values on the Rotor Gene- 6 software. A correction for gDNA contamination was performed however the levels of gDNA detected were insignificant. The log of the relative abundance value (log R) for each sample was calculated using the equation log*R* = −log*A · C~t~*+log*A* ~ref~ *· C~t,~* ~ref~ where *A* is the amplification efficiency and *C~t~* is the cycle threshold. The reference gene was *dld* (D-lactate dehydrogenase). To determine statistical significance between log*R* values for each gene and each mutant, a one-way ANOVA was performed, followed by a Tukey\'s Honest Significant Difference post hoc test.

Results and Discussion {#s3}
======================

Sucrose is an important industrial feedstock for bioprocesses [@pone.0088688-Archer1], [@pone.0088688-Arifin1] and sucrose utilisation is widespread in pathogenic *E. coli* strains [@pone.0088688-Moritz1]. However, significant variation in growth rates on sucrose have been observed between wild-type strains [@pone.0088688-Moritz1] and laboratory strains modified to express the *csc* regulon from EC3132 typically grow slowly when compared to the WT EC3132 strain [@pone.0088688-Bockmann1], [@pone.0088688-Tsunekawa1], [@pone.0088688-Bruschi1]. These observations suggest that non-*csc* genes might contribute to the sucrose utilisation and/or induction phenotype in *E. coli*. To investigate this, we used *E. coli* W, a non-pathogenic wilt type (WT) strain which uses a *csc* regulon to confer sucrose utilisation [@pone.0088688-Archer1]. Although *E. coli* W grows as quickly on sucrose, induction of the *csc* regulon requires concentrations ≥1% of sucrose [@pone.0088688-Arifin1], [@pone.0088688-Sabri1].

Generation and screening of the mutant library {#s3a}
----------------------------------------------

A Tn*5* transposon mutagenesis library was constructed and screened for growth on minimal medium supplemented with either 2% or 0.2% sucrose. From the library of 10,000 kanamycin resistant mutants, 32 mutants with altered sucrose fermentation patterns (improved utilization at low sucrose, or lack of sucrose utilization) were identified. All except one of the strains that could not utilize sucrose had insertions in the *csc* operon (four in *cscB* and three in *cscA*). This supports our earlier studies showing that these two genes are essential for sucrose utilization in wild type *E. coli* W [@pone.0088688-Sabri1]. Previous research has demonstrated that truncation or deletion of the *cscR* gene can confer de-repression at low sucrose [@pone.0088688-Arifin1], [@pone.0088688-Bockmann1], [@pone.0088688-Sabri1]; consistent with this, four mutants that could utilize sucrose at 0.2% had insertions in *cscR*. These *csc* mutants were excluded from further studies.

Improved sucrose fermentation can also be attributed to spontaneous mutation events within the *csc* regulon [@pone.0088688-Jahreis1], [@pone.0088688-Bockmann1]. Frequently, these mutations occur within the repressor or the repressor binding site [@pone.0088688-Jahreis1], and lead to de-repression of the regulon, allowing growth on low concentrations of sucrose. To exclude this as a possible reason for improved sucrose utilization, the *csc* regulons of the remaining strains were sequenced. A further ten Tn*5* strains were found to contain spontaneous point mutations in the *csc* regulon. Eight of these were in *cscB*, one in a putative operator binding site within the *csc* promoter region (*cscKB*OP), and one in *cscR* (Q132\*) that resulted in truncation of the repressor protein. The mutation in the *cscKB*OP has been observed previously and was shown to confer growth on low sucrose [@pone.0088688-Jahreis1], [@pone.0088688-Bockmann1]. Interestingly, nearly all of the mutations identified in this study were located within *cscB* despite the fact that only one CscB mutation (Q353H) that allows for growth on low sucrose has been characterized previously [@pone.0088688-Jahreis1]. Mutations in *cscB* which improve sucrose transport [@pone.0088688-Jahreis1], [@pone.0088688-Bockmann1], [@pone.0088688-Frillingos1] can also relieve repression, presumably as a consequence of increased concentrations of intracellular sucrose (or fructose and/or glucose) which can then facilitate de-repression. All of these *csc* gene mutants were excluded from further study.

Deletion of the trehalose repressor gene treR permits growth on low sucrose {#s3b}
---------------------------------------------------------------------------

Once the *csc* mutants were removed from the study, the Tn*5* insertion sites within the 11 remaining Tn*5* mutants were identified using direct Sanger sequencing of purified genomic DNA ([Table 3](#pone-0088688-t003){ref-type="table"}). The single mutant that was unable to utilize sucrose contained a Tn*5* insertion within *cyaA* (adenylate cyclase), a gene which is essential for cyclic AMP (cAMP) production. Two cAMP-CrpA binding sites are found in the bi-directional *csc* promoter [@pone.0088688-Sabri2], and regulation of both the *cscA* and *cscKB* transcription units by cAMP has been demonstrated previously [@pone.0088688-Jahreis1]. In the absence of cAMP, activation of the *csc* regulon by cAMP-CrpA cannot occur; this most likely provides an explanation for why this strain cannot grow on sucrose. Of the remaining mutants, Tn*5* insertions in four mutants were found to disrupt genes associated with DNA replication, recombination and repair. Disruption of these genes may lead to an increased potential for accumulation of mutations elsewhere in the chromosome that we could not identify; for this reason, these strains were not examined further.

10.1371/journal.pone.0088688.t003

###### Tn*5* insertion sites in selected non-*csc* insertion/mutation strains.

![](pone.0088688.t003){#pone-0088688-t003-3}

  Strain             Genotype            Suc                               Comment                                            COG group description                COG
  -------- ---------------------------- ----- ----------------------------------------------------------------- ------------------------------------------------- -----
  Tn2            W *appC::*Tn*5*         \+              Cytochrome *bd*-II terminal oxidase subunit                    Energy production and conversion            C
  Tn9            W *cyaA::*Tn*5*          −                      Adenylate cyclase, family 3                                   Signal transduction                  T
  Tn32      W *mhpR::*Tn*5 cscB* L363F   \+                 Mhp operon transcriptional activator                                  Transcription                     K
  Tn33           W *mutS::*Tn*5*         \+              Methyl-directed DNA mismatch repair protein                DNA replication, recombination and repair       L
  Tn54           W *pi349::*Tn*5*        \+                           phage recombinase                             DNA replication, recombination and repair       L
  Tn61           W *treR::*Tn*5*         \+    HTH-type transcriptional repressor, trehalose PTS uptake operon                    Transcription                     K
  Tn63           W *gspK::*Tn*5*         \+                  General secretion pathway protein K                           Cell motility and secretion              N
  Tn65           W *gltS::*Tn*5*         \+               Sodium/glutamate symport carrier protein                     Amino acid transport and metabolism          E
  Tn68            W *hyp::*Tn*5*         \+                    conserved hypothetical protein                                        Unknown                        S
  Tn84           W *truA::*Tn*5*         \+                      tRNA pseudouridine synthase                     Translation, ribosomal structure and biogenesis    J
  Tn87           W *treR::*Tn*5*         \+    HTH-type transcriptional regulator, trehalose PTS uptake operon                    Transcription                     K

Strains were grown on M9S2 and M9S20. Sucrose phenotype (Suc) is listed as positive if the strain can grow on low sucrose (0.2%) and negative if it cannot grow on sucrose at all. COG (Clusters of Orthologous Genes) groupings are listed.

Transposon insertions were also found within two transcriptional regulators (two isolates with insertions in *treR* and one with an insertion in *mhpR*) as well as the membrane bound transporters *gltS* and *gspK*. To investigate the role of these genes, three independently isolated site-directed deletion mutants of each of the four targets were constructed in the wild type W strain using homologous recombination. Of the genes targeted, only the *treR* mutants were able to grow on 0.2% sucrose. The growth rate of the WΔ*treR* mutant on 0.2% sucrose was not statistically different from the two original mutant strains (Tn61 and Tn87; ρ≥0.05; [Table 4](#pone-0088688-t004){ref-type="table"}), suggesting that deletion of *treR* is responsible for the phenotype. The lack of growth in the other deletion mutants suggests that the original phenotype observed was not due to the transposon insertion. It is possible that those mutants carry additional mutations which confer the ability to grow on 0. 2% sucrose; the frequency of spontaneous mutations observed in the *csc* regulon even in the absence of selection pressure supports this hypothesis.

10.1371/journal.pone.0088688.t004

###### Summary of the growth characteristics of the WΔ*treR* double mutants generated in this study.

![](pone.0088688.t004){#pone-0088688-t004-4}

                 glucose 1%   sucrose 2%   sucrose 0.2%                         
  ------------- ------------ ------------ -------------- ----- ---- ----------- -------------------------------------
  W                 +++          +++        1.36±0.12     \-    −       \-                       n/a
  WΔcsc*R*          +++          +++        1.42±0.06     Ns    ++   0.65±0.01   [\*\*](#nt108){ref-type="table-fn"}
  Tn61              +++          +++        1.01±0.04     Ns    ++   0.19±0.03                   ns
  Tn87              +++          +++        1.05±0.13     Ns    ++   0.28±0.03                   ns
  WΔtreR            +++          +++        0.99±0.16     ns    ++   0.35±0.02                   \-
  WΔtreRΔtreB       +++          +++        1.18±0.33     ns    −       \-                       n/a
  WΔtreRΔtreC       +++          +++        1.29±0.21     ns    ++   0.42±0.04                   ns
  WΔtreRΔcscB       +++           −             \-        n/a   ND      \-                       n/a
  WΔtreRΔcscA       +++           −             \-        n/a   ND      \-                       n/a

Strains plated on M9 minimal media supplemented with various carbon sources as indicated in the table. Phenotype, +++ fast growth (sizable colonies in 15 h); ++, growth (small colonies after 15 h); −, no growth after 24 h; ND, not determined. Statistical significance was determined using the Kruskal-Wallis test combined with Dunn\'s Multiple Comparison test. ρ value^1^, comparison between each sample and W; ρ value^2^, comparison between each sample and WΔ*treR*.

\*\*, ρ value≤0.01;

ns, not significant; n/a, not applicable.

The trehalose-specific enzyme II (TreB) is required for growth of WΔtreR on low sucrose {#s3c}
---------------------------------------------------------------------------------------

In *E. coli*, uptake of trehalose occurs *via* the phosphoenolpyruvate (PEP)∶carbohydrate phosphotransferase system (PTS) [@pone.0088688-Klein1], [@pone.0088688-Horlacher1]. In this system the trehalose-specific enzyme EIICB^Tre^ (TreB) transports trehalose into the cell with concomitant phosphorylation to deliver trehalose-6-phosphate [@pone.0088688-Boos1] (see [Figure 1A](#pone-0088688-g001){ref-type="fig"}). EIICB^Tre^ does not have a covalently-bound EIIA domain for phosphorylation of the transported sugar; like other non-glucose PTS transporters in the EIIBC domain type, it relies on kinase activity provided by EIIA^Glc^, a component of the primary glucose transport system [@pone.0088688-Boos1]--[@pone.0088688-Marechal1]. The transported trehalose 6-phosphate is hydrolyzed by TreC to produce glucose and glucose-6-phosphate [@pone.0088688-Klein1], [@pone.0088688-Rimmele1] which are directed into central carbon metabolism. Expression of *treB* and *treC* is activated in the absence of glucose and repressed by TreR in the absence of trehalose-6-phosphate [@pone.0088688-Horlacher1].

![Models for disaccharide transport and utilisation by EIIC^Tre^.\
In phospho*enol*pyruvate∶carbohydrate transport systems, sugars (in this case, trehalose) are transported with concomitant phosphorylation *via* a PTS-associated phosphorylation cascade (A). For the trehalose PTS, the transporter protein EIIBC^Tre^ consists of a permease (EIIC^Tre^) and a kinase (EIIB^Tre^) domain. EIIB^Tre^ accepts a phosphate group from EIIA^Glc^ in the presence of trehalose transport. EIIC^Glc^ accepts a phosphate from HPr, which in turn accepts a phosphate from the PEP-dependent histidine-protein kinase EI^Glc^, which accepts its phosphate group from phospho*enol*pyruvate. Phosphorylated trehalose is cleaved by TreC to yield 1× phosphorylated (G6P) and 1× unphosphorylated glucose; both of these feed into central carbon metabolism (CCM) (the unphosphorylated glucose is phosphorylated by glucokinase, Glk). In the presence of PTS-mediated sugar transport, the concentration of unphosphorylated EIIA^Glc^ increases; unphosphorylated EIIA^Glc^ transcriptionally inhibits non-PTS permeases and catabolic enzymes that generate internal inducers of the various catabolic regulons (a mechanism known as inducer exclusion) *via* a variety of transcription factors [@pone.0088688-Postma1]. The trehalose PTS has also been shown to transport maltose [@pone.0088688-Decker1] (B). In this case, transport is thought to be achieved through facilitated diffusion by EIIC^Tre^ and the maltose not phosphorylated by EIIB^Tre^. In the absence of PTS-mediated phosphorylation, carbon catabolite repression is released: the concentration of phosphorylated EIIA^Glc^ remains high; this activates adenylate cyclase (AC), resulting in an increase in intracellular cAMP concentration; cAMP complexes with the transcription factor CrpA; and cAMP-CrpA transcriptionally activates a wide variety of non-PTS transport systems, including the ABC transporter for maltose. Sucrose transport by TreB (C) may occur with or without concomitant phosphorylation, but most likely occurs without phosphorylation (see text). Transport results in sufficient intracellular sucrose to facilitate induction of the *csc* regulon; phosphorylated EIIA^Glc^ remains high, and the *csc* regulon is activated through cAMP-CrpA. Transported unphosphorylated sucrose may be metabolised *via csc* gene products; phosphorylated sucrose is most likely not metabolised. Once the *csc* genes are induced, sucrose can be imported through the CscB permease and cleaved by the CscA invertase into fructose and sucrose. Fructose is phosphorylated by the CscK fructokinase, and glucose is phosphorylated by Glk; both phosphorylated sugars feed into CCM.](pone.0088688.g001){#pone-0088688-g001}

Substrate plasticity is common in disaccharide transporters [@pone.0088688-Peng1]--[@pone.0088688-Decker1]. Functional analysis of the trehalose PTS has shown that maltose can enter the cell *via* the TreB transporter [@pone.0088688-Decker1] (see [Figure 1B](#pone-0088688-g001){ref-type="fig"}). Trehalose is a glucose α(1→1) disaccharide, and maltose is a glucose α(1→4) disaccharide. Interestingly, maltose is transported by facilitated diffusion, and enters the cell in an unphosphorylated state [@pone.0088688-Decker1]. The substrate flexibility of TreB led us to hypothesize that it might also be able to transport sucrose, a glucose-fructose disaccharide, and that deletion of the *treR* repressor might allow production of TreB at sufficient levels to transport sucrose into the cell to allow for cell growth.

To determine if deletion of the *treR* gene allows for the uptake of sucrose *via* TreB, a double WΔ*treR*Δ*treB* deletion mutant was constructed and tested for growth on 0.2% sucrose. In support of our hypothesis, this mutant was unable to grow on sucrose ([Table 4](#pone-0088688-t004){ref-type="table"}), suggesting that sucrose uptake *via* TreB is essential for the growth of WΔ*treR* on 0.2% sucrose.

The trehalose hydrolase TreC is not required for growth of WΔtreR on low sucrose {#s3d}
--------------------------------------------------------------------------------

Maltose is thought to be transported by TreB in an unphosphorylated form *via* facilitated diffusion [@pone.0088688-Decker1]. Maltose is not recognised by the TreC trehalose hydrolase [@pone.0088688-Rimmele1], however, transport *via* TreB allows induction of the maltose ABC transporter [@pone.0088688-Decker1] (see [Figure 1B](#pone-0088688-g001){ref-type="fig"}). To determine if hydrolysis by TreC is required for low sucrose utilisation in WΔ*treR*, a double WΔ*treR*Δ*treC* deletion mutant was also constructed. Growth of WΔ*treR*Δ*treC* on 0.2% sucrose ([Table 4](#pone-0088688-t004){ref-type="table"}) was indistinguishable from the WΔ*treR* strain (ρ≥0.05), indicating that, like for maltose, processing of the incoming sucrose by TreC is not required for growth on low concentrations of sucrose. This is consistent with transport studies showing that TreC does not recognise unphosphorylated sucrose [@pone.0088688-Rimmele1]; however, there is no information available in the literature for transport or otherwise of phosphorylated sucrose (see comments below).

cscB is required for the growth of WΔtreR on low sucrose {#s3e}
--------------------------------------------------------

Based on the results from the WΔ*treR*Δ*treB* mutant, growth on low concentrations of sucrose in the presence of a *treR* mutation relies on uptake of sucrose *via* TreB. To determine if sucrose uptake *via* TreB is sufficient to support growth in a WΔ*treR* background, a double WΔ*treR*Δ*cscB* deletion mutant was constructed and tested for growth on 0.2% and 2% sucrose. WΔ*treR*Δ*cscB* was unable to grow on either concentration ([Table 4](#pone-0088688-t004){ref-type="table"}), demonstrating that *cscB* is also required for growth in WΔ*treR* mutants, and that the uptake of sucrose *via* TreB alone is insufficient for growth.

Sucrose uptake via TreB de-represses the csc operon allowing for growth on low concentrations of sucrose {#s3f}
--------------------------------------------------------------------------------------------------------

Based on the results from the mutagenesis studies, growth of the WΔ*treR* mutant in 0.2% sucrose relies on the uptake of sucrose *via* TreB to induce the *csc* regulon. We hypothesised that sucrose transported by TreB, while insufficient to support growth, can trigger de-repression of the *csc* operon, allowing for uptake of sucrose *via* CscB and subsequent processing of the sucrose into glucose and fructose by CscA. To confirm this hypothesis, QRT-PCR was performed on W, WΔ*treR*, WΔ*treR*Δ*treB* and WΔ*treR*Δ*cscB* cultured on minimal media containing 1% glycerol supplemented with 0.2% sucrose ([Figure 2](#pone-0088688-g002){ref-type="fig"}). Glycerol was included to support the growth of strains that would otherwise not grow on sucrose alone. The *cscA* gene was used as a reporter of transcription. The wild-type strain with 2% sucrose was included as a positive control for *cscA* expression under induced conditions.

![Relative expression of *cscA* in the WΔ*treR* mutants.\
The expression level of *cscA* was determined by qRT-PCR and log normalized to the level of *dld* (D-lactate dehydrogenase). As a control, W was cultured in minimal media containing 1% glycerol and 2% sucrose. The test strains W, WΔ*treR*, WΔ*treR*Δ*treB* and WΔ*treR*Δ*cscB* were cultured in minimal media containing 1% glycerol and 0.2% sucrose. Statistical significance was determined using one way ANOVA followed by Tukey\'s HSD test. The average relative expression was determined from three independent mutants (or three biological replicates of W). Error bars are SEM; \* p≤0.05, \*\* p≤0.01, \*\*\* p≤0.001.](pone.0088688.g002){#pone-0088688-g002}

As expected, expression of *cscA* was strongest in the WT strain under strongly inducing conditions (2% sucrose). Expression was also observed at a lower level on 0.2% sucrose, even though 0.2% sucrose as a sole carbon source is insufficient to support growth of this strain. This is not surprising: in the absence of sucrose, a basal level of expression (leaky expression) from the *csc* regulon is expected as this allows for the cell to detect sucrose should it become available. In the WΔ*treR* mutant, the expression of *cscA* was significantly higher than that of the WT control cultured under the same conditions (ρ≤0.001), indicating that induction the *csc* regulon occurs when this mutant is cultured on 0.2% sucrose. The degree of induction in the W*ΔtreR* mutant was less than that of W cultured in 2% sucrose; this may be due to the low sucrose transport rates of TreR resulting in inducer concentrations that are insufficient for full deactivation of CscR.

In the double deletion strain WΔ*treR*Δ*treB* in the presence of 0.2% sucrose, expression of *cscA* returns to levels that are statistically indistinguishable (ρ≥0.05) from the WT on 0.2% sucrose, providing additional evidence that sucrose uptake *via* TreB is essential for growth of the WΔ*treR* mutant on 0.2% sucrose. In the final double deletion strain WΔ*treR*Δ*cscB*, expression of *cscA* was increased compared to W when grown in the presence of 0.2% sucrose (ρ≤0.05), even though the ability to grow on sucrose as a sole carbon source is lost. This result demonstrates that induction of the *csc* regulon in WΔ*treR*Δ*cscB* occurs in the absence of sucrose uptake *via* CscB. Importantly, expression of *cscA* in the WΔ*treR*Δ*cscB* mutant was lower than that observed in the WΔ*treR* mutant (ρ≤0.01). This finding indicates that sucrose uptake *via* CscB does contribute to the level of induction observed in the original strain. We hypothesize that the increased induction observed in WΔ*treR* is the result of feedback in which the regulon is initially induced by sucrose transported by TreB, and subsequent expression of the *csc* regulon and uptake of sucrose *via* CscB results in further induction.

Sucrose transport by TreB: phosphorylated or unphosphorylated? {#s3g}
--------------------------------------------------------------

A question that remains is whether sucrose is transported in a phosphorylated form, like trehalose [@pone.0088688-Boos1], [@pone.0088688-Klein2] ([Figure 1A](#pone-0088688-g001){ref-type="fig"}), or unphosphoryated, as maltose is thought to be [@pone.0088688-Decker1] ([Figure 1B](#pone-0088688-g001){ref-type="fig"}). One possible explanation for the lack of growth in the WΔ*treR*Δ*cscB* mutant is that the sucrose is phosphorylated and cannot be metabolized ([Figure 1C](#pone-0088688-g001){ref-type="fig"}); this is plausible given that the W genome does not encode a sucrose-6-phosphate hydrolase [@pone.0088688-Archer1]. The phosphorylated sucrose might still act as an inducer of the *csc* regulon, allowing transport of sucrose *via* CscB. Under this scenario, phosphorylated EIIA^Glc^ remains at relatively high concentrations, since transport levels are low. Phosphorylated EIIA^Glc^ activates adenylate cyclase, increasing cellular cAMP concentrations. An increase in cellular cAMP would allow release of catabolite repression *via* the cAMP-CrpA transcriptional activator, activating the *csc* regulon (which responds to cAMP [@pone.0088688-Jahreis1]; see [Figure 1C](#pone-0088688-g001){ref-type="fig"}). Thus, cellular conditions would be permissive for transcription of the *csc* regulon. However, it is known that transport rates of EII enzymes that can carry out facilitated diffusion increase significantly when they are phosphorylated [@pone.0088688-Postma1]. EII enzyme phosphorylation is linked to carbohydrate phosphorylation; consequently, one would expect transport rates to increase, and potentially be sufficient to support growth. This situation occurs in PTS-mediated sensing of carbon sources for PTSs that can transport unphosphorylated carbohydrates, and provides a mechanism for rapid upregulation of transport in the presence of preferred substrates. Feedback of this cycle results in increased transport rates, more phosphorylation of EIIB^Tre^, and decreased concentrations phosphorylated EIIA^Glc^. In this case, that would ultimately result in repression of the *csc* regulon (see [Figure 1A and 1C](#pone-0088688-g001){ref-type="fig"}). Furthermore, the increase in unphosphorylated EIIA^Glc^ is likely to result in transcriptional inhibition of the *csc* regulation ('inducer exclusion'; [@pone.0088688-Postma1]) (see [Figure 1A](#pone-0088688-g001){ref-type="fig"}). Clearly, however, this does not happen: the *csc* regulon is instead induced, and the requirement of CscB demonstrates that transport of sucrose by EIIB^Tre^ remains at very low levels. Transport of phosphorylated sucrose is therefore only a likely mechanism if phosphorylation of EIIB^Tre^ does not significantly enhance transport of sucrose.

Alternatively, sucrose might be transported in an unphosphorylated state ([Figure 1C](#pone-0088688-g001){ref-type="fig"}). Under this scenario, the unphosphorylated sucrose facilitates induction of the *csc* regulon and EIIA^Glc^ remains high, allowing cAMP-CrpA mediated de-repression in concert with induction ([Figure 1C](#pone-0088688-g001){ref-type="fig"}). The sucrose is cleaved by CscA, and the resulting hexoses are phosphorylated by CscK/Glk before feeding into central carbon metabolism. Transport of sucrose by EIIB^Tre^ remains at very low rates and, in the absence of CscB, is insufficient to support growth. This scenario most easily explains the observed experimental data and is consistent with currently-understood models of PTS-mediated transport.

Conclusion {#s3h}
----------

Direct demonstration of sucrose transport by TreB using available methods is technically challenging due to the very low levels of sucrose transported. However, the mutant analysis presented here provides compelling evidence that TreB can transport sucrose, albeit at very low concentrations. We also showed that the transported sucrose is sufficient to facilitate induction of the *csc* operon. Interestingly, a very similar association is shown between the trehalose transporter and maltose catabolism, controlled in this case by an ABC transporter [@pone.0088688-Decker1]. TreB is also highly homologous to the EII^Scr^ of the sucrose-specific PTS encoded on the pUR400 plasmid of enteric bacteria [@pone.0088688-Klein2], which can also transport maltose and lactose [@pone.0088688-Hardesty1]. Maltose porins can also transport sucrose and trehalose efficiently [@pone.0088688-Wang1]. Furthermore, CscB in fact transports maltose at a higher affinity than sucrose [@pone.0088688-Peng1]. These observations suggest that the substrate plasticity shared by the enzymes might be related to their structural similarity, and that trehalose/sucrose/maltose might share common biochemical properties from a transport point of view. As is the case with direct demonstration of transport in the first instance, direct demonstration of what form the sucrose is transported in is technically challenging due to the low levels transported, and this question remains unanswered. Regardless, to our knowledge, this is the first time that TreB has been shown to transport sucrose.
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